Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Surg Res ; 226: 8-14, 2018 06.
Article in English | MEDLINE | ID: mdl-29661292

ABSTRACT

BACKGROUND: The aim of the study is to evaluate in vivo and in vitro effects of etanercept, a soluble tumor necrosis factor receptor, on the contractile responses of superior mesenteric artery in an experimental mesenteric ischemia and reperfusion model. MATERIAL AND METHODS: After obtaining animal ethics committee approval, 24 Sprague-Dawley rats were allocated to three groups. Control group (Gr C, n = 6) underwent a sham operation, whereas ischemia/reperfusion and treatment groups underwent 90 min ischemia and 24-h reperfusion (Gr I/R, n = 12; Gr I/R+E, n = 6). The treatment group received 5 mg/kg etanercept intravenously at the beginning of reperfusion. At the end of reperfusion, all animals were sacrificed, and third branch of superior mesenteric artery was dissected for evaluation of contractile responses. In vitro effects of etanercept on vasocontractile responses were also evaluated. The excised ileums were analyzed under light microscope. Two-way analysis of variance following Bonferroni post hoc test was used for evaluation of contractile responses. RESULTS: Endothelin-1 and phenylephrine-mediated vasocontractile sensitivity were found increased in Gr I/R when compared with Gr C. Both intravenous administration and organ bath incubation of etanercept decreased the sensitivity of contractile agents for Gr I/R. Mucosal injury, lamina propria disintegration, and denuded villous tips were observed in Gr I/R, whereas the epithelial injury and the subepithelial edema were found to be milder in Gr I/R+E. CONCLUSIONS: Etanercept can be a promising agent in mesenteric ischemic reperfusion injury as it does not only inhibit inflammation by blocking tumor necrosis factor-α in circulation but also restores vascular contractility during reflow. These findings support an unexplained recuperative effect of drug beyond its anti-inflammatory effects.


Subject(s)
Etanercept/pharmacology , Gastrointestinal Agents/pharmacology , Mesenteric Artery, Superior/drug effects , Mesenteric Ischemia/drug therapy , Reperfusion Injury/drug therapy , Animals , Disease Models, Animal , Endothelin-1/metabolism , Etanercept/therapeutic use , Gastrointestinal Agents/therapeutic use , Humans , Ileum/blood supply , Ileum/physiopathology , Infusions, Intravenous , Intestinal Mucosa/blood supply , Intestinal Mucosa/pathology , Male , Mesenteric Artery, Superior/physiopathology , Mesenteric Artery, Superior/surgery , Mesenteric Ischemia/etiology , Mesenteric Ischemia/pathology , Mesenteric Ischemia/physiopathology , Mesentery/blood supply , Mesentery/pathology , Mesentery/physiopathology , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiopathology , Rats , Rats, Sprague-Dawley , Reperfusion Injury/etiology , Reperfusion Injury/pathology , Reperfusion Injury/physiopathology , Treatment Outcome , Tumor Necrosis Factor-alpha/antagonists & inhibitors
2.
J Pediatr Surg ; 47(8): 1560-5, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22901917

ABSTRACT

BACKGROUND: After abdominal surgery, the formation of postoperative adhesion is a serious problem. The aim of the study is to evaluate the efficacy of 2 different pulmonary surfactants, poractant and beractant, on adhesion prevention in an experimental model. MATERIALS AND METHODS: An experimental intraabdominal adhesion model was created in 18 adult female rats by cecal abrasion. The rats were randomly assigned to 3 groups. Group I received no further treatment, whereas groups II and III received intraperitoneal poractant and beractant, respectively, before closing the incision. On the 15th postoperative day, all rats underwent relaparotomy, intraabdominal adhesions were scored macroscopically according to Canbaz scoring system, and the cecum in each animal was evaluated microscopically. RESULTS: The median adhesion scores of group II and III rats were significantly lower when compared with group I (P = .02). Group III had a lower median adhesion score than did group II, but this did not reach significance (P > .05). CONCLUSION: These observations suggest that intraperitoneal instillation of both pulmonary surfactants is associated with lower adhesion scores, higher adhesion-free cases, and improved histologic findings.


Subject(s)
Abdomen/surgery , Biological Products/therapeutic use , Cecum/surgery , Phospholipids/therapeutic use , Pulmonary Surfactants/therapeutic use , Tissue Adhesions/prevention & control , Animals , Biological Products/administration & dosage , Cattle , Cecum/injuries , Cecum/pathology , Drug Evaluation, Preclinical , Female , Instillation, Drug , Laparotomy , Peritoneal Cavity , Phospholipids/administration & dosage , Pulmonary Surfactants/administration & dosage , Random Allocation , Rats , Rats, Wistar , Swine , Tissue Adhesions/etiology
3.
World J Gastroenterol ; 14(23): 3729-32, 2008 Jun 21.
Article in English | MEDLINE | ID: mdl-18595140

ABSTRACT

AIM: To examine the possible effects of honey supplementation on hepatic damage due to obstruction of the common bile duct in an experimental rat model. METHODS: The study was performed with 30 male rats divided into three groups: a sham group, an obstructive jaundice group, and an obstructive jaundice plus honey group. At the end of the study period, the animals were sacrificed, and levels of nitric oxide (NO), and NO synthase (NOS) activities were measured in liver tissues, and levels of adenosine deaminase (ADA) and alanine transaminase (ALT) activities were measured in serum. RESULTS: Blood ALT and ADA activities were significantly elevated in the jaundice group as compared to those of the sham group. In the obstructive jaundice plus honey group, blood ALT and ADA activities were significantly decreased as compared to those of the jaundice group. In erythrocytes and liver tissues, NO levels were found to be significantly higher in the obstructive jaundice plus honey group compared to those of the sham group. Additionally, NO levels were found to be significantly higher in liver tissues from the animals in the obstructive jaundice plus honey group than those of the jaundice group. CONCLUSION: Honey was found to be beneficial in the prevention of hepatic damage due to obstruction of the common bile duct.


Subject(s)
Cholestasis/complications , Honey , Jaundice, Obstructive/drug therapy , Liver/drug effects , Protective Agents/pharmacology , Adenosine Deaminase/blood , Alanine Transaminase/blood , Animals , Cholestasis/drug therapy , Cholestasis/metabolism , Cholestasis/pathology , Common Bile Duct/surgery , Disease Models, Animal , Jaundice, Obstructive/etiology , Jaundice, Obstructive/metabolism , Jaundice, Obstructive/pathology , Ligation , Liver/enzymology , Liver/pathology , Male , Nitric Oxide/metabolism , Nitric Oxide Synthase/metabolism , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...